Author

Wolfgang H. Jost

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned

Patients with advanced Parkinson’s disease (PD) often need to continue with device-aided therapies (DAT), such as intestinal and subcutaneous infusion therapies. Recently, continuous subcutaneous administration of foslevodopa/foscarbidopa (LDp/CDp) has emerged as a new therapeutic method. Two years after its approval i...

D. Weise, Tobias Warnecke, Carsten Buhmann et al. · Neurological Research and Pr... · 0 citations

Open access Sep 2026

Nigrostriatal free-water imaging and volumetry outperform quantitative T1 in neurodegenerative Parkinson syndromes.

BACKGROUND The relative value of nigrostriatal volumetry, quantitative T1 relaxation, and multicompartment diffusion MRI in neurodegenerative Parkinson syndromes is unclear. OBJECTIVES To compare quantitative T1 relaxation and diffusion microstructure imaging-derived free fluid fraction (V-CSF) in the putamen and sub...

N. Schröter, Lucas A. Both, Wolfgang H. Jost et al. · Parkinsonism & Related Disor... · 0 citations